Transaction · 0001193125-26-418096

Patel Sanjiv

Patel Sanjiv, PRES, reported an open-market or private sale at Relay Therapeutics, Inc. involving 48199.000000 shares for an estimated $872401.90. Reported holdings after the transaction were 471301.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES
RLAYRelay Therapeutics, Inc.
Filing timeOct 08
Trade dateOct 07, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded9.28%Shares sold ÷ (holdings after + shares sold). Estimated position before: 519,500 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$17.41
Pre-filing
1mo ago +9.4%1w ago +3.7%1d ago +7.6%
Returns since
7d30d90d180d1y

RLAY price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RLAY since 2026-10-08Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-418096
Common Stock
Transaction date
Oct 07, 2026
Filed Oct 08, 2026, 09:29 PM · 1d delay
Shares
48.1k sh
$18.10 per share
Estimated value
-$872k
Computed from shares × price
Holdings after
471k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.

  2. F2

    This transaction was executed in multiple trades at prices ranging from $17.87 to $18.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to p…

  3. F3

    These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownersh…

Original filing · 0001193125-26-418096
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RLAY